Annual Operating Expenses
$15.97 M
-$65.90 K-0.41%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual total operating expenses is $15.97 million, with the most recent change of -$65.90 thousand (-0.41%) on December 31, 2022.
- During the last 3 years, DFFN annual operating expenses has risen by +$4.42 million (+38.27%).
Performance
DFFN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$2.29 M
-$1.97 M-46.26%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly total operating expenses is $2.29 million, with the most recent change of -$1.97 million (-46.26%) on June 30, 2023.
- Over the past year, DFFN quarterly operating expenses has dropped by -$1.95 million (-46.00%).
Performance
DFFN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DFFN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | -46.0% |
| 3 y3 years | +38.3% | -37.3% |
| 5 y5 years | +40.7% | -25.5% |
DFFN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | at low | -49.7% | at low |
| 5 y | 5-year | -0.4% | -27.7% | -56.5% | at low |
| alltime | all time | -13.1% | -99.7% | -63.2% | -145.6% |
Diffusion Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $2.29 M(-46.3%) |
| Mar 2023 | - | $4.27 M(+0.4%) |
| Dec 2022 | $15.97 M(-0.4%) | $4.25 M(+45.4%) |
| Sep 2022 | - | $2.92 M(-31.2%) |
| Jun 2022 | - | $4.25 M(-6.8%) |
| Mar 2022 | - | $4.55 M(+31.4%) |
| Dec 2021 | $16.04 M(+0.4%) | $3.47 M(-14.5%) |
| Sep 2021 | - | $4.05 M(+5.8%) |
| Jun 2021 | - | $3.83 M(-18.2%) |
| Mar 2021 | - | $4.68 M(+14.6%) |
| Dec 2020 | $15.97 M(+38.3%) | $4.09 M(-22.5%) |
| Sep 2020 | - | $5.27 M(+44.2%) |
| Jun 2020 | - | $3.66 M(+23.8%) |
| Mar 2020 | - | $2.96 M(-0.1%) |
| Dec 2019 | $11.55 M(-4.0%) | $2.96 M(-3.0%) |
| Sep 2019 | - | $3.05 M(+16.4%) |
| Jun 2019 | - | $2.62 M(-10.2%) |
| Mar 2019 | - | $2.92 M(+3.7%) |
| Dec 2018 | $12.03 M(+6.0%) | $2.81 M(+1.0%) |
| Sep 2018 | - | $2.79 M(-9.5%) |
| Jun 2018 | - | $3.08 M(-8.1%) |
| Mar 2018 | - | $3.35 M(+36.6%) |
| Dec 2017 | $11.35 M(-38.2%) | $2.45 M(-26.7%) |
| Sep 2017 | - | $3.35 M(+12.2%) |
| Jun 2017 | - | $2.98 M(+16.1%) |
| Mar 2017 | - | $2.57 M(+1.0%) |
| Dec 2016 | $18.37 M(+186.8%) | $2.54 M(-56.2%) |
| Sep 2016 | - | $5.80 M(+52.6%) |
| Jun 2016 | - | $3.80 M(-38.9%) |
| Mar 2016 | - | $6.22 M(+142.2%) |
| Dec 2015 | $6.41 M(-19.4%) | $2.57 M(+90.8%) |
| Sep 2015 | - | $1.35 M(+3.7%) |
| Jun 2015 | - | $1.30 M(+8.8%) |
| Mar 2015 | - | $1.19 M(-5.2%) |
| Dec 2014 | $7.94 M | $1.26 M(-64.2%) |
| Sep 2014 | - | $3.51 M(+94.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $1.80 M(+31.4%) |
| Mar 2014 | - | $1.37 M(-73.5%) |
| Dec 2013 | $10.86 M(+58.3%) | $5.17 M(+400.6%) |
| Sep 2013 | - | $1.03 M(-73.4%) |
| Jun 2013 | - | $3.88 M(+399.9%) |
| Mar 2013 | - | $776.50 K(-23.3%) |
| Dec 2012 | $6.86 M(-31.9%) | $1.01 M(-32.3%) |
| Sep 2012 | - | $1.49 M(-35.4%) |
| Jun 2012 | - | $2.31 M(+13.3%) |
| Mar 2012 | - | $2.04 M(-7.4%) |
| Dec 2011 | $10.07 M(+47.8%) | $2.21 M(-46.6%) |
| Sep 2011 | - | $4.14 M(+101.1%) |
| Jun 2011 | - | $2.06 M(+22.8%) |
| Mar 2011 | - | $1.67 M(-22.4%) |
| Dec 2010 | $6.82 M(+131.2%) | $2.16 M(+31.3%) |
| Sep 2010 | - | $1.64 M(-9.7%) |
| Jun 2010 | - | $1.82 M(+52.2%) |
| Mar 2010 | - | $1.20 M(-5.8%) |
| Dec 2009 | $2.95 M(+141.1%) | $1.27 M(+123.5%) |
| Sep 2009 | - | $567.80 K(+33.4%) |
| Jun 2009 | - | $425.70 K(+11.8%) |
| Mar 2009 | - | $380.90 K(-10.4%) |
| Dec 2008 | $1.22 M(+2091.6%) | $425.10 K(+47.5%) |
| Sep 2008 | - | $288.20 K(+23.0%) |
| Jun 2008 | - | $234.40 K(-14.8%) |
| Mar 2008 | - | $275.20 K(-126.3%) |
| Dec 2007 | $55.80 K(+33.2%) | -$1.04 M(-487.9%) |
| Sep 2007 | - | $269.30 K(-30.7%) |
| Jun 2007 | - | $388.80 K(-12.1%) |
| Mar 2007 | - | $442.30 K(+1322.2%) |
| Dec 2006 | $41.90 K(-54.6%) | $31.10 K(+763.9%) |
| Sep 2006 | - | $3600.00(-91.9%) |
| Jun 2006 | - | $44.70 K(+1141.7%) |
| Mar 2006 | - | $3600.00 |
| Dec 2005 | $92.20 K(-98.7%) | - |
| Dec 1999 | $7.27 M(+96.5%) | - |
| Dec 1998 | $3.70 M | - |
FAQ
- What is Diffusion Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual operating expenses year-on-year change?
- What is Diffusion Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly operating expenses year-on-year change?
What is Diffusion Pharmaceuticals annual total operating expenses?
The current annual operating expenses of DFFN is $15.97 M
What is the all time high annual operating expenses for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual total operating expenses is $18.37 M
What is Diffusion Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, DFFN annual total operating expenses has changed by -$65.90 K (-0.41%)
What is Diffusion Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of DFFN is $2.29 M
What is the all time high quarterly operating expenses for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly total operating expenses is $6.22 M
What is Diffusion Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, DFFN quarterly total operating expenses has changed by -$1.95 M (-46.00%)